MediXall Group (MDXL) Stock Statistics & Valuation Metrics

MediXall Group has a market cap or net worth of $1.15M. The enterprise value is $4.97M.

MediXall Group has 205,506,010 shares outstanding. The number of shares has decreased by -2.65% in one year.

MediXall Group’s return on equity (ROE) is 0.70 and return on invested capital (ROIC) is 145.40%.

The current PE Ratio of MediXall Group is ―. MediXall Group’s PEG ratio is 0.00029.

In the last 12 months, MediXall Group had revenue of 309.42K and earned -4.56M in profits. Earnings per share was -0.04.

In the last 12 months, operating cash flow was -1.20M and capital expenditures 0.00, giving a free cash flow of -1.20M billion.

MediXall Group pays an annual dividend of ―, resulting in a dividend yield of ―

MediXall Group upcoming earnings date is ―, ―.

MediXall Group as a current ratio of <0.01, with Debt / Equity ratio of -58.71%

In the past 12 months, MediXall Group has paid 0.00 in taxes.

MediXall Group EV to EBITDA ratio is -1.00, with an EV/FCF ratio of -3.15.

MediXall Group has $31.92K in cash and marketable securities with $430.43K in debt, giving a net cash position of -$398.51K billion.

Gross margin is 23.56%, with operating margin of -1265.64%, and net profit margin of -1474.82%.

The average price target for MediXall Group is ―, which is 11.43% higher than the current price. The consensus rating is ―